References
- Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005;105:3768-85. https://doi.org/10.1182/blood-2004-09-3502
- Kempf W, Sander CA. Classification of cutaneous lymphomas: an update. Histopathology 2010;56:57-70. https://doi.org/10.1111/j.1365-2559.2009.03455.x
- Bradford PT, Devesa SS, Anderson WF, Toro JR. Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. Blood 2009;113:5064-73. https://doi.org/10.1182/blood-2008-10-184168
- Sidiropoulos KG, Martinez-Escala ME, Yelamos O, Guitart J, Sidiropoulos M. Primary cutaneous T-cell lymphomas: a review. J Clin Pathol 2015;68:1003-10. https://doi.org/10.1136/jclinpath-2015-203133
- Lee HS, Suh KS, Lee DY, Cho KH, Oh SH, Kim SC, et al. Cutaneous lymphoma in Korea: a nationwide retrospective study. Acta Derm Venereol 2016;96:535-9. https://doi.org/10.2340/00015555-2283
- Bekkenk MW, Geelen FA, van Voorst Vader PC, Heule F, Geerts ML, van Vloten WA, et al. Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood 2000;95:3653-61. https://doi.org/10.1182/blood.V95.12.3653
- Strauss M, Kolkova Z, Laurian N, Zohar Y. Cutaneous malignant lymphoma of the nasal tip. Ann Otol Rhinol Laryngol 1986;95(2 Pt 1):208-10. https://doi.org/10.1177/000348948609500222
- Fujita H, Nagatani T, Miyazawa M, Wada H, Koiwa K, Komatsu H, et al. Primary cutaneous anaplastic large cell lymphoma successfully treated with low-dose oral methotrexate. Eur J Dermatol 2008;18:360-1. https://doi.org/10.1684/ejd.2008.0420
- Rodenhuis S, Kremer JM, Bertino JR. Increase of dihydrofolate reductase in peripheral blood lymphocytes of rheumatoid arthritis patients treated with low-dose oral methotrexate. Arthritis Rheum 1987;30:369-74. https://doi.org/10.1002/art.1780300402
- Cooper JA Jr, White DA, Matthay RA. Drug-induced pulmonary disease. Part 1: cytotoxic drugs. Am Rev Respir Dis 1986;133:321-40.
- Searles G, McKendry RJ. Methotrexate pneumonitis in rheumatoid arthritis: potential risk factors. Four case reports and a review of the literature. J Rheumatol 1987;14:1164-71.
- Weinblatt ME, Fraser P. Elevated mean corpuscular volume as a predictor of hematologic toxicity due to methotrexate therapy. Arthritis Rheum 1989;32:1592-6. https://doi.org/10.1002/anr.1780321214
Cited by
- Anaplastic Large Cell Lymphoma with Generalized Skin Lesion in Childhood: Clinical Case vol.19, pp.6, 2019, https://doi.org/10.15690/vsp.v19i6.2157
- Cutaneous Anaplastic Large Cell Lymphoma: A Case Report about Masking Effect of Facial Masks in the COVID-19 Pandemic vol.9, pp.7, 2021, https://doi.org/10.1097/gox.0000000000003783
- Early diagnosis and surgical treatment of primary cutaneous marginal zone B-cell lymphomas of the face in an Asian patient vol.22, pp.5, 2019, https://doi.org/10.7181/acfs.2021.00472